Where is the trace? Molecular imaging of vulnerable atherosclerotic plaques

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 2, 2007, Pages 151-158

  Langer, Harald ^a   Schönberger, Tanja ^a   Bigalke, Boris ^a   Gawaz, Meinrad ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Atherosclerosis; Plaque imaging; Plaque rupture; Radionuclide imaging; Thrombogenicity

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; RADIOISOTOPE; TRACER;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; CHEMOTAXIS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FATALITY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART SCINTISCANNING; HIGH RISK POPULATION; HUMAN; INFLAMMATION; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RELIABILITY; REVIEW; SYSTEMATIC REVIEW; THROMBOGENICITY; THROMBOSIS;

ATHEROSCLEROSIS; DISEASE SUSCEPTIBILITY; HUMANS; INFLAMMATION; RADIONUCLIDE IMAGING; THROMBOSIS;

EID: 33947252972     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-969028     Document Type: Review

References (43)

1. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997;80:10F-19F
2. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation 2001;103:604-616
3. Schroeder S, Kopp AF, Baumbach A, et al. Noninvasive detection and evaluation of atherosclerotic coronary plaques with multislice computed tomography. J Am Coll Cardiol 2001;37:1430-1435
4. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation 2001;104:1682-1687
5. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 2003;108:1772-1778
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126
7. Libby P. Inflammation in atherosclerosis. Nature 2002;420: 868-874
8. Ogawa M, Ishino S, Mukai T, et al. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245-1250
9. Rudd JH, Warburton EA, Fryer TD, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708-2711
10. Gawaz M, Neumann FJ, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 1998;98:1164-1171
11. Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an auto-radiographic study. Circulation 2001;104:203-208
12. Virgolini I, Muller C, Fitscha P, Chiba P, Sinzinger H. Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis. Prog Clin Biol Res 1990;355:271-280
13. Haubner R, Wester HJ, Burkhart F, et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 2001;42:326-336
14. Janssen ML, Oyen WJ, Dijkgraaf I, et al. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model. Cancer Res 2002;62:6146-6151
15. Matter CM, Schuler PK, Alessi P, et al. Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin. Circ Res 2004;95:1225-1233
16. Virgolini I, Rauscha F, Lupattelli G, et al. Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 1991;18:948-951
17. Virgolini I, Angelberger P, O'Grady J, Sinzinger H. Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage. Eur J Nucl Med 1991;18:944-947
18. Tsimikas S, Palinski W, Witztum JL. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:95-100
19. Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002;90:22L-27L
20. Tsimikas S, Shortal BP, Witztum JL, Palinski W. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression. Arterioscler Thromb Vasc Biol 2000;20:689-697
21. Iuliano L, Signore A, Vallabajosula S, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis 1996;126:131-141
22. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am J Pathol 1995;147:251-266
23. Thomas WA, Scott RF, Florentin RA, Reiner JM, Lee KT. Population dynamics of arterial cells during atherogenesis. XI. Slowdown in multiplication and death rates of lesion smooth muscle cells in swine during the period 105-165 days after balloon endothelial cell denudation followed by a hyperlipidemic diet. Exp Mol Pathol 1981;35:153-162
24. Thomas WA, Kim DN, Lee KT, Reiner JM, Schmee J. Population dynamics of arterial cells during atherogenesis. XIII. Mitogenic and cytotoxic effects of a hyperlipidemic (HL) diet on cells in advanced lesions in the abdominal aortas of swine fed an HL diet for 270-345 days. Exp Mol Pathol 1983;39:257-270
25. Johnson LL, Schofield L, Donahay T, Narula N, Narula J. 99mTc-annexin V imaging for in vivo detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005;46:1186-1193
26. Narula J, Acio ER, Narula N, et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 2001;7:1347-1352
27. Hofstra L, Liem IH, Dumont EA, et al. Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 2000;356:209-212
28. Kolodgie FD, Petrov A, Virmani R, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003;108:3134-3139
29. Schafers M, Riemann B, Kopka K, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004;109:2554-2559
30. Langer H, Gawaz M. Molecular imaging of vulnerable atherosclerotic plaques. Future Cardiology 2006;2:113-122
31. Minar E, Ehringer H, Dudczak R, et al. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke 1989; 20:27-33
32. Moriwaki H, Matsumoto M, Handa N, et al. Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography. Arterioscler Thromb Vasc Biol 1995;15: 2234-2240
33. Smyth JV, Dodd PD, Walker MG. Indium-111 platelet scintigraphy in vascular disease. Br J Surg 1995;82:588-595
34. Vallabhajosula S. Technetium-99m-P748, platelet specific techtide for imaging arterial thrombus: preclinical studies in a canine model of intra-arterial thrombus. J Nucl Med 2005;7: 152(abst)
35. Cerqueira MD, Stratton JR, Vracko R, Schaible TF, Ritchie JL. Noninvasive arterial thrombus imaging with 99mTc monoclonal antifibrin antibody. Circulation 1992;85:298-304
36. Greco C, Di Loreto M, Ciavolella M, et al. Immunodetection of human atherosclerotic plaque with 125I-labeled monoclonal antifibrin antibodies. Atherosclerosis 1993;100: 133-139
37. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001;86:189-197
38. Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003;102:449-461
39. Massberg S, Konrad I, Bultmann A, et al. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 2004;18:397-399
40. Moers A, Nieswandt B, Massberg S, et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 2003;9:1418-1422
41. Gawaz M, Konrad I, Hauser AI, et al. Non-invasive imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost 2005;93:910-913
42. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-250
43. Farb A, Burke AP, Tang AL, et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354-1363